{84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Introvale 91 Day]
- RxCUI
- 1020155
- RxNorm name
- {84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Introvale 91 Day]
- Display name
- INTROVALE 91 DAY (Pack)
- Full name
- {84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Introvale 91 Day]
- Term type
- BPCK
- Status
- Active
- Strength
- mixed
- Dose form
- Pack
- Route
- Pack
- Updated
- 2026-11-16 14:53:39
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 112010
- Active start
- 112010
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| ethinyl estradiol | 0.03 MG / 1 EACH | ethinyl estradiol | ethinyl estradiol |
| levonorgestrel | 0.15 MG / 1 EACH | levonorgestrel | levonorgestrel |
| inert ingredients | 1 MG / 1 EACH | inert ingredients | inert ingredients |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Pack | 746839 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| ethinyl estradiol | 4124 |
| levonorgestrel | 6373 |
| inert ingredients | 748794 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Introvale 91 Day Pack | 1 | NAMES |
| RxNorm Name | {84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Introvale 91 Day] | 1 | NAMES |
| RxNorm Synonym | Introvale 91 Day Pack | 1 | NAMES |
| TTY | BPCK | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 1020155 | 1 | CODES |
| MMSL_CODE | BD13014 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 70700-117-87 | 70700-117 | Introvale Levonorgestrel and Ethinyl Estradiol | Xiromed, LLC. | ANDA079064 |
| 70700-208-88 | 70700-208 | INTROVALE Levonorgestrel and Ethinyl Estradiol tablets | Xiromed LLC | ANDA200490 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA079064 | 70700-117 | Introvale Levonorgestrel and Ethinyl Estradiol | ANDA | Xiromed, LLC. |
| ANDA200490 | 70700-208 | INTROVALE Levonorgestrel and Ethinyl Estradiol tablets | ANDA | Xiromed LLC |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INTROVALE | LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS | Xiromed LLC | 24abb5e1-5be4-87e7-404c-d8c2db25ffd0 | 2024-10-15 | Boxed warning, Warnings, Adverse reactions | 70700-208-88 70700-208 70700020887 70700020888 1020155 |
| Introvale | LEVONORGESTREL AND ETHINYL ESTRADIOL | Xiromed, LLC. | f5bc2427-3a18-e3e6-a058-210688e9c446 | 2022-06-09 | Boxed warning, Warnings, Adverse reactions | 70700-117-87 70700-117 70700011787 1020155 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f5bc2427-3a18-e3e6-a058-210688e9c446 | {84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Introvale 91 Day] [BPCK] · Introvale 91 Day Pack [PSN] · Introvale 91 Day Pack [SY] | 3 | 7 | These highlights do not include all the information needed to use INTROVALE safely and effectively. See full prescribing information for INTROVALE. Introvale ® Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg for oral use Initial U.S. Approval: 1982 | 20220609 |
| 24abb5e1-5be4-87e7-404c-d8c2db25ffd0 | {84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Introvale 91 Day] [BPCK] · Introvale 91 Day Pack [PSN] · Introvale 91 Day Pack [SY] | 3 | 1 | These highlights do not include all the information needed to use INTROVALE safely and effectively. See full prescribing information for INTROVALE . INTROVALE ® (levonorgestrel and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1982 | 20241015 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 24abb5e1-5be4-87e7-404c-d8c2db25ffd0 | These highlights do not include all the information needed to use INTROVALE safely and effectively. See full prescribing information for INTROVALE . INTROVALE ® (levonorgestrel and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1982 | Xiromed LLC | 20241015 |
| f5bc2427-3a18-e3e6-a058-210688e9c446 | These highlights do not include all the information needed to use INTROVALE safely and effectively. See full prescribing information for INTROVALE. Introvale ® Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg for oral use Initial U.S. Approval: 1982 | Xiromed, LLC. | XIROMED PHARMA ESPANA, S.L. | Aspen Oss B.V. | 20220609 |
| 60a47d8c-d95f-4f81-9706-4954921fabbb | National Council for Prescription Drug Programs | 20130211 | |
| 7e60a323-6156-4ee5-9bed-11f1e5a2f405 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | G03AD | Emergency contraceptives | ATC1-4 | levonorgestrel | |
| ATC | L02AA | Estrogens | ATC1-4 | ethinyl estradiol | |
| ATC | G03CA | Natural and semisynthetic estrogens, plain | ATC1-4 | ethinyl estradiol | |
| ATC | G03AC | Progestogens | ATC1-4 | levonorgestrel | |
| ATC | G03AA | Progestogens and estrogens, fixed combinations | ATC1-4 | ethinyl estradiol / levonorgestrel | |
| ATC | G03AB | Progestogens and estrogens, sequential preparations | ATC1-4 | ethinyl estradiol / levonorgestrel | |
| FDASPL | D045167 | Progesterone Congeners | CHEM | has_chemical_structure | levonorgestrel |
| FDASPL | N0000175825 | Estrogen | EPC | has_epc | ethinyl estradiol |
| FDASPL | N0000175602 | Progestin | EPC | has_epc | levonorgestrel |
| FDASPL | N0000175832 | Progestin-containing Intrauterine System | EPC | has_epc | levonorgestrel |
| FDASPL | N0000000100 | Estrogen Receptor Agonists | MOA | has_moa | ethinyl estradiol |
| FDASPL | N0000175830 | Inhibit Ovum Fertilization | PE | has_pe | levonorgestrel |
| MEDRT | D004997 | Ethinyl Estradiol | CHEM | has_ingredient | ethinyl estradiol |
| MEDRT | D016912 | Levonorgestrel | CHEM | has_ingredient | levonorgestrel |
| MEDRT | D000022 | Abortion, Spontaneous | DISEASE | induces | levonorgestrel |
| MEDRT | D018248 | Adenoma, Liver Cell | DISEASE | ci_with | levonorgestrel |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | ethinyl estradiol |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | levonorgestrel |
| MEDRT | D002539 | Cerebral Arterial Diseases | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D002561 | Cerebrovascular Disorders | DISEASE | ci_with | levonorgestrel |
| MEDRT | D003324 | Coronary Artery Disease | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D003327 | Coronary Disease | DISEASE | ci_with | levonorgestrel |
| MEDRT | D003920 | Diabetes Mellitus | DISEASE | ci_with | levonorgestrel |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | levonorgestrel |
| MEDRT | D016889 | Endometrial Neoplasms | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D016889 | Endometrial Neoplasms | DISEASE | ci_with | levonorgestrel |
| MEDRT | D020773 | Headache Disorders | DISEASE | ci_with | levonorgestrel |
| MEDRT | D006349 | Heart Valve Diseases | DISEASE | ci_with | levonorgestrel |
| MEDRT | D019584 | Hot Flashes | DISEASE | may_treat | ethinyl estradiol |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | levonorgestrel |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D007006 | Hypogonadism | DISEASE | may_treat | ethinyl estradiol |
| MEDRT | D007565 | Jaundice | DISEASE | ci_with | levonorgestrel |
| MEDRT | D007674 | Kidney Diseases | DISEASE | ci_with | levonorgestrel |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | levonorgestrel |
| MEDRT | D008113 | Liver Neoplasms | DISEASE | ci_with | levonorgestrel |
| MEDRT | D008594 | Menopause, Premature | DISEASE | may_treat | ethinyl estradiol |
| MEDRT | D008595 | Menorrhagia | DISEASE | may_treat | ethinyl estradiol |
| MEDRT | D009376 | Neoplasms, Hormone-Dependent | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D015663 | Osteoporosis, Postmenopausal | DISEASE | may_prevent | ethinyl estradiol |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | ethinyl estradiol |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | levonorgestrel |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | levonorgestrel |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D016649 | Primary Ovarian Insufficiency | DISEASE | may_treat | ethinyl estradiol |
| MEDRT | D011471 | Prostatic Neoplasms | DISEASE | may_treat | ethinyl estradiol |
| MEDRT | D013923 | Thromboembolism | DISEASE | ci_with | levonorgestrel |
| MEDRT | D013923 | Thromboembolism | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | levonorgestrel |
| MEDRT | D064424 | Tobacco Use | DISEASE | ci_with | ethinyl estradiol |
| MEDRT | D014029 | Tobacco Use Disorder | DISEASE | ci_with | levonorgestrel |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | ci_with | levonorgestrel |
| MEDRT | N0000000100 | Estrogen Receptor Agonists | MOA | has_moa | ethinyl estradiol |
| MEDRT | N0000000185 | Progestational Hormone Receptor Agonists | MOA | has_moa | levonorgestrel |
| MEDRT | N0000008311 | Bone Formation Stimulation | PE | has_pe | ethinyl estradiol |
| MEDRT | N0000008595 | Decreased Embryonic Implantation | PE | has_pe | ethinyl estradiol |
| MEDRT | N0000008595 | Decreased Embryonic Implantation | PE | has_pe | levonorgestrel |
| MEDRT | N0000009072 | Hypothalamic Endocrine Activity Alteration | PE | has_pe | levonorgestrel |
| MEDRT | N0000178478 | Increased Blood Pressure | PE | ci_pe | levonorgestrel |
| MEDRT | N0000009717 | Inhibit Ovulation | PE | has_pe | ethinyl estradiol |
| MEDRT | N0000009717 | Inhibit Ovulation | PE | has_pe | levonorgestrel |
| MEDRT | N0000009902 | Vaginal Function Alteration | PE | has_pe | ethinyl estradiol |
| MEDRT | N0000008289 | Aromatic hydroxylation | PK | has_pk | ethinyl estradiol |
| MEDRT | N0000000045 | Fecal Excretion | PK | has_pk | ethinyl estradiol |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | ethinyl estradiol |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | ethinyl estradiol |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA079064 |
| CODES | ANDA | ANDA200490 |
| CODES | VUID | 4032278 |
| NAMES | Prescribable Synonym | Introvale 91 Day Pack |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | Veterans Health Administration National Drug File |